ATE497405T1 - Zusammensetzungen mit modulatoren des g-protein- gekoppelten rezeptors zur behandlung von makuladegeneration - Google Patents
Zusammensetzungen mit modulatoren des g-protein- gekoppelten rezeptors zur behandlung von makuladegenerationInfo
- Publication number
- ATE497405T1 ATE497405T1 AT06738066T AT06738066T ATE497405T1 AT E497405 T1 ATE497405 T1 AT E497405T1 AT 06738066 T AT06738066 T AT 06738066T AT 06738066 T AT06738066 T AT 06738066T AT E497405 T1 ATE497405 T1 AT E497405T1
- Authority
- AT
- Austria
- Prior art keywords
- macular degeneration
- coupled receptor
- treatment
- protein
- compositions containing
- Prior art date
Links
- 208000002780 macular degeneration Diseases 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 4
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 title abstract 3
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 title abstract 3
- 206010064930 age-related macular degeneration Diseases 0.000 abstract 3
- 206010029113 Neovascularisation Diseases 0.000 abstract 2
- 239000005557 antagonist Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000005590 Anaphylatoxin C5a Receptor Human genes 0.000 abstract 1
- 108010059426 Anaphylatoxin C5a Receptor Proteins 0.000 abstract 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 abstract 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Surgical Instruments (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66075205P | 2005-03-11 | 2005-03-11 | |
| PCT/US2006/008960 WO2006099330A2 (en) | 2005-03-11 | 2006-03-13 | Compositions comprising modulators of g-protein-coupled receptor for treatment of macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE497405T1 true ATE497405T1 (de) | 2011-02-15 |
Family
ID=36992349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06738066T ATE497405T1 (de) | 2005-03-11 | 2006-03-13 | Zusammensetzungen mit modulatoren des g-protein- gekoppelten rezeptors zur behandlung von makuladegeneration |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090117171A1 (de) |
| EP (1) | EP1861114B1 (de) |
| AT (1) | ATE497405T1 (de) |
| AU (1) | AU2006223108A1 (de) |
| DE (1) | DE602006019948D1 (de) |
| WO (1) | WO2006099330A2 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8168584B2 (en) | 2005-10-08 | 2012-05-01 | Potentia Pharmaceuticals, Inc. | Methods of treating age-related macular degeneration by compstatin and analogs thereof |
| EP2148691B1 (de) | 2007-02-05 | 2015-05-20 | Apellis Pharmaceuticals, Inc. | Compstatin analoga zur behandlung von entzündungserkrankungen der atemwege |
| EP2424556A4 (de) * | 2009-04-27 | 2013-07-31 | Jerini Ophthalmic Inc | Verzögert freigesetzte formulierungen aus peptidomimetischen arzneien und verwendungen davon |
| US9421240B2 (en) | 2010-06-22 | 2016-08-23 | Apellis Pharmaceuticals, Inc. | Compstatin analogs for treatment of neuropathic pain |
| EP2468295A1 (de) | 2010-12-21 | 2012-06-27 | Affiris AG | Impfstoffe basierend auf Komplementprotein C5a Peptide |
| CA2840270C (en) | 2011-06-22 | 2023-09-26 | Apellis Pharmaceuticals, Inc. | Methods of treating chronic disorders with complement inhibitors |
| US10220002B2 (en) * | 2011-12-02 | 2019-03-05 | Board Of Regents Of The University Of Nebraska | Controlled-release peptide compositions and uses thereof |
| EP2809344B1 (de) | 2012-02-02 | 2016-08-24 | ESBATech - a Novartis Company LLC | Antikörper enthaltende retardformulierung zur applikation am auge |
| US10035822B2 (en) | 2012-11-15 | 2018-07-31 | Apellis Pharmaceuticals, Inc. | Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods |
| WO2014152391A1 (en) | 2013-03-15 | 2014-09-25 | Apellis Pharmaceuticals, Inc. | Cell-penetrating compstatin analogs and uses thereof |
| KR20180090785A (ko) | 2015-10-07 | 2018-08-13 | 아펠리스 파마슈티컬스 인코포레이티드 | 투여 요법 |
| EP3405577B8 (de) | 2016-01-20 | 2023-02-15 | 396419 B.C. Ltd. | Zusammensetzungen und verfahren zur hemmung des faktors d |
| WO2018136827A1 (en) | 2017-01-20 | 2018-07-26 | Vitrisa Therapeutics, Inc. | Stem-loop compositions and methods for inhibiting factor d |
| BR112019020955A2 (pt) | 2017-04-07 | 2020-05-05 | Apellis Pharmaceuticals, Inc. | regimes de dosagem e composições e métodos relacionados |
| JP2021507884A (ja) | 2017-12-15 | 2021-02-25 | アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 投与レジメンならびに関連組成物および方法 |
| US20220356234A1 (en) | 2019-10-02 | 2022-11-10 | Alexion Pharmaceuticals, Inc. | Complement inhibitors for treating drug-induced complement-mediated response |
| CN115667925A (zh) | 2020-05-15 | 2023-01-31 | 阿雷克森制药公司 | 使用细胞外囊泡来检测补体激活的方法以及其用于评估和/或监测补体介导的疾病的治疗的用途 |
| WO2024238422A1 (en) | 2023-05-12 | 2024-11-21 | Alexion Pharmaceuticals, Inc. | Use of a panel of lectins for detection of complement biomarkers in urine extracellular vesicles |
| WO2024238421A1 (en) | 2023-05-12 | 2024-11-21 | Alexion Pharmaceuticals, Inc. | Use of biomarkers for the identification and treatment of complement-mediated disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO755097A0 (en) * | 1997-06-25 | 1997-07-17 | University Of Queensland, The | Receptor agonist and antagonist |
| DK1287364T3 (da) * | 2000-04-29 | 2009-03-02 | Univ Iowa Res Found | Diagnostisk og terapi til makulære degenerationsrelaterede lidelser |
| AUPS160602A0 (en) * | 2002-04-08 | 2002-05-16 | University Of Queensland, The | Therapeutic method |
| WO2004041160A2 (en) * | 2002-10-30 | 2004-05-21 | University Of Kentucky Research Foundation | Methods and animal model for analyzing age-related macular degeneration |
-
2006
- 2006-03-13 EP EP06738066A patent/EP1861114B1/de not_active Expired - Lifetime
- 2006-03-13 AT AT06738066T patent/ATE497405T1/de not_active IP Right Cessation
- 2006-03-13 US US11/375,587 patent/US20090117171A1/en not_active Abandoned
- 2006-03-13 WO PCT/US2006/008960 patent/WO2006099330A2/en not_active Ceased
- 2006-03-13 AU AU2006223108A patent/AU2006223108A1/en not_active Abandoned
- 2006-03-13 DE DE602006019948T patent/DE602006019948D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20090117171A1 (en) | 2009-05-07 |
| DE602006019948D1 (de) | 2011-03-17 |
| WO2006099330A3 (en) | 2007-07-12 |
| EP1861114B1 (de) | 2011-02-02 |
| WO2006099330A2 (en) | 2006-09-21 |
| EP1861114A2 (de) | 2007-12-05 |
| AU2006223108A1 (en) | 2006-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006019948D1 (de) | Koppelten rezeptors zur behandlung von makuladegeneration | |
| AU2025271125A1 (en) | Methods for treating or preventing ophthalmological conditions | |
| MA29976B1 (fr) | Utilisation d'inhibiteurs de la voie du complement pour traiter des maladies oculaires. | |
| EA200701218A1 (ru) | Композиция для лечения ретинол-ассоциированных заболеваний | |
| ATE491444T1 (de) | Verfahren zur behandlung von schmerzen durch verabreichung eines nervenwachstumsfaktor- antagonisten und eines nsaid und diese enthaltende zusammensetzung | |
| EA201000787A1 (ru) | Антигенсвязывающие белки | |
| JP2020537644A5 (de) | ||
| SI2780368T1 (en) | INGREDIENTS AND PROCEDURES FOR INCREASING PURE MASS AND MICROWAVE WITH SPECIFIC ANTAGONISING OF GDF8 AND / OR ACTIVITY A | |
| ATE426413T1 (de) | Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen | |
| AR066660A1 (es) | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento | |
| TW200633709A (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions | |
| MA52288B1 (fr) | Modulateurs d'enzymes de modification de méthyle, compositions et utilisations de ceux-ci | |
| CA2820681C (en) | Use of chimeric antigen receptor-modified t cells to treat cancer | |
| GEP20125628B (en) | Pharmaceutical compositions containing antagonist anti-cd40 antibody | |
| EA200900662A1 (ru) | Лечение синдрома "сухого глаза" с помощью тестостерона и прогестагена | |
| WO2008035246A3 (en) | Compositions containing quaternary ammonium compounds | |
| EA033130B1 (ru) | Способы и композиции для улучшения когнитивной функции | |
| WO2006015775A3 (en) | Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders | |
| AR090972A1 (es) | Metodo para tratar amd en pacientes resistentes a la terapia anti-vegf | |
| CL2004001996A1 (es) | Aptameros anti-vegf (factor de crecimiento endotelial vascular) con bloqueo nucleotidico 5'-5' o 3'-3' invertido, composicion que lo contiene, util para trastornos de neovascularizacion. | |
| EA200800291A1 (ru) | Способы и композиции для лечения офтальмологических состояний | |
| EA200800336A1 (ru) | Лечение состояний, связанных с присутствием макромолекулярных агрегатов, в частности глазных расстройств | |
| JP2018530574A5 (de) | ||
| ATE495164T1 (de) | Thiadiazolderivate zur behandlung neurodegenerativer krankheiten | |
| WO2008013983A3 (en) | Opsin stabilizing compounds and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |